Microbial biomass in relation to primary succession on arctic deglaciated moraines

Microbial biomass in arctic soil was examined in relation to a primary succession on arctic deglaciated moraines in Ny-Alesund, Svalbard (79°N, 12°E). Soil samples at four study sites representing different successional stages were collected at every 1cm depth from the soil surface to 3cm depth in early August 1995. Microbial biomass was measured with a substrate-induced respiration procedure. The microbial biomass was highest at the soil surface (0-1cm depth) in all successional stages, and decreased to a negligible amount at 3cm depth. Mean microbial biomass in 0-2cm layer increased from 0.06mgCg^ soil d. w. in the youngest site to 1.03mgC g^ soil d. w. in the oldest site, which is comparable to ecosystems in warmer regions. Throughout all successional stages, there was positive high correlation between soil carbon or nitrogen content and microbial biomass

Sweet taste disorder and vascular complications in patients with abnormal glucose tolerance

AbstractBackgroundIt remains unknown whether taste disorders can be a risk factor for micro- and macro-vascular diseases in patients with abnormal glucose tolerance.MethodsA cross-sectional study in a nationally representative samples of 848 and 849 US adults (aged ≥40years) with diabetes or prediabetes who had sweet and salt taste disorders, respectively, from the National Health and Nutrition Examination Survey 2011–2012.ResultsAmong the study population, 5.7% had sweet taste disorder and 8.6% had salt taste disorder. These data correspond to approximately 1.5 million and 1.8 million individuals with abnormal glucose tolerance aged 40years or older in the US population, respectively. In the adjusted model, sweet taste disorder was significantly associated with complication of ischemic heart disease (adjusted odds ratio [OR], 2.45; 95% confidence interval [CI], 1.03–5.81; P=0.04). Moreover, sweet taste disorder in patients with diabetes was significantly associated with diabetic retinopathy (adjusted OR, 2.89; 95% CI, 1.09–7.69; P=0.03) and diabetic nephropathy (adjusted OR, 3.17; 95% CI, 1.07–9.36; P=0.03). Meanwhile, salt taste disorder was not significantly associated with diabetic retinopathy, diabetic nephropathy, ischemic heart disease, or stroke. Total sugar intake was significantly higher in patients with sweet taste disorder than in those without it, whereas total daily intake of carbohydrate did not differ significantly. No significant association was observed between salt taste disorder and daily intake of sodium after multivariate analysis.ConclusionsSweet taste disorder in patients with abnormal glucose tolerance was associated with increased sugar intake and vascular complications

Soil respiration in a high arctic glacier foreland in Ny-Alesund, Svalbard

Soil respiration rates were measured in a successional glacier foreland in Ny-_lesund, Svalbard, and the amount of CO2 efflux during the plant-growing season was estimated using a simple regression model. Three study sites (Site 1, Site 2 and Site 3) were set up along with the primary succession in the deglaciated area of East Br_gger glacier in Ny-_lesund, Svalbard, Norway (79‹N 12‹E). Another study site, Site RB, was set up on a riverbed in the Bay River between Site 2 and Site 3. Soil respiration (SR), air temperature at 10 cm height (AT), soil surface temperature (SST) and soil temperature at 1 cm depth (ST) were measured at the four study sites with an open-airflow system using an infra-red gas analyzer from July to August, 1995. The mean soil respiration rate varied among the four sites: 6.2, 44, 63 and 3.7 mg CO2 m-2 h-1 at Site 1, Site 2, Site 3 and Site RB, respectively. These differences in the soil respiration rate among the four sites corresponded with the soil organic amount, microbial biomass, and root biomass. The soil respiration rate showed the best correlation with AT at Site 1, Site 2 and Site RB, and with ST at Site 3. The cumulative amount of CO2 efflux calculated using correlation equations obtained from the above relationships between SR and AT or ST was 5.8, 46, 69 and 3.3 g CO2 m-2 at Site 1, Site 2, Site 3 and Site RB, respectively, for two months (from July to August, 1995). These values were extremely low compared to those of warmer ecosystems, such as low-arctic tundra, temperate mixed forests, and tropical moist forests

Morphological and genetic differences on vegetative plant

第2回極域科学シンポジウム/第33回極域生物シンポジウム 11月18日（金） 統計数理研究所 3階リフレッシュフロ

Cerebral capillary blood flow upsurge during REM sleep is mediated by A2a receptors

睡眠中の脳のリフレッシュ機構を解明. 京都大学プレスリリース. 2021-08-27.Sleep is generally viewed as a period of recovery, but how the supply of cerebral blood flow (CBF) changes across sleep/wake states has remained unclear. Here, we directly observe red blood cells (RBCs) within capillaries, where the actual substance exchange between the blood and neurons/glia occurs, by two-photon microscopy. Across multiple cortical areas, average capillary CBF is largely increased during rapid eye movement (REM) sleep, whereas it does not differ between periods of active wakefulness and non-REM sleep. Capillary RBC flow during REM sleep is further elevated following REM sleep deprivation, suggesting that capillary CBF reflects REM sleep pressure. At the molecular level, signaling via adenosine A2a receptors is crucial; in A2a-KO mice, capillary CBF upsurge during REM sleep is dampened, and effects of REM sleep pressure are abolished. These results provide evidence regarding the dynamics of capillary CBF across sleep/wake states and insights to the underlying mechanisms

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

「コロナ制圧タスクフォース」COVID-19患者由来の血液細胞における遺伝子発現の網羅的解析 --重症度に応じた遺伝子発現の変化には、ヒトゲノム配列の個人差が影響する--. 京都大学プレスリリース. 2022-08-23.Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has caused millions of deaths, where comprehensive understanding of disease mechanisms is still unestablished. In particular, studies of gene expression dynamics and regulation landscape in COVID-19 infected individuals are limited. Here, we report on a thorough analysis of whole blood RNA-seq data from 465 genotyped samples from the Japan COVID-19 Task Force, including 359 severe and 106 non-severe COVID-19 cases. We discover 1169 putative causal expression quantitative trait loci (eQTLs) including 34 possible colocalizations with biobank fine-mapping results of hematopoietic traits in a Japanese population, 1549 putative causal splice QTLs (sQTLs; e.g. two independent sQTLs at TOR1AIP1), as well as biologically interpretable trans-eQTL examples (e.g., REST and STING1), all fine-mapped at single variant resolution. We perform differential gene expression analysis to elucidate 198 genes with increased expression in severe COVID-19 cases and enriched for innate immune-related functions. Finally, we evaluate the limited but non-zero effect of COVID-19 phenotype on eQTL discovery, and highlight the presence of COVID-19 severity-interaction eQTLs (ieQTLs; e.g., CLEC4C and MYBL2). Our study provides a comprehensive catalog of whole blood regulatory variants in Japanese, as well as a reference for transcriptional landscapes in response to COVID-19 infection

DOCK2 is involved in the host genetics and biology of severe COVID-19

「コロナ制圧タスクフォース」COVID-19疾患感受性遺伝子DOCK2の重症化機序を解明 --アジア最大のバイオレポジトリーでCOVID-19の治療標的を発見--. 京都大学プレスリリース. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target

ボルナ病ウイルス2型のヌクレオプロテインはボルナ病ウイルス1型のRNA依存性RNAポリメラーゼ活性を高める同種のタンパク質である

京都大学新制・課程博士博士(医学)甲第23786号医博第4832号新制||医||1057(附属図書館)京都大学大学院医学研究科医学専攻(主査)教授 小柳 義夫, 教授 髙折 晃史, 教授 齊藤 博英学位規則第4条第1項該当Doctor of Medical ScienceKyoto UniversityDFA

Reverse Genetics and Artificial Replication Systems of Borna Disease Virus 1

Borna disease virus 1 (BoDV-1) is a neurotropic RNA virus belonging to the family Bornaviridae within the order Mononegavirales. Whereas BoDV-1 causes neurological and behavioral disorders, called Borna disease (BD), in a wide range of mammals, its virulence in humans has been debated for several decades. However, a series of case reports in recent years have established the nature of BoDV-1 as a zoonotic pathogen that causes fatal encephalitis in humans. Although many virological properties of BoDV-1 have been revealed to date, the mechanism by which it causes fatal encephalitis in humans remains unclear. In addition, there are no effective vaccines or antiviral drugs that can be used in clinical practice. A reverse genetics approach to generating replication-competent recombinant viruses from full-length cDNA clones is a powerful tool that can be used to not only understand viral properties but also to develop vaccines and antiviral drugs. The rescue of recombinant BoDV-1 (rBoDV-1) was first reported in 2005. However, due to the slow nature of the replication of this virus, the rescue of high-titer rBoDV-1 required several months, limiting the use of this system. This review summarizes the history of the reverse genetics and artificial replication systems for orthobornaviruses and explores the recent progress in efforts to rescue rBoDV-1